breast cancer stem cells therapy resistance
Breast Cancer Stem Cells & Therapy Resistance
$262.00 Original price was: $262.00.$4.99Current price is: $4.99. Add to cart
Sale!

Breast Cancer Stem Cells & Therapy Resistance

Original price was: $262.00.Current price is: $4.99.

-98%

Flash Sale: Any ebook for just 4.99 USD only

  • Pay with Any Debit/Credit Card
  • Affordable Prices for Readers
Guaranteed Safe Checkout

The Indestructible Seed: Breast Cancer Stem Cells & Therapy Resistance

You can blast a breast tumor with radiation and poison it with chemotherapy until it completely disappears from the MRI. But if a single, dormant Breast Cancer Stem Cell survives the assault, the tumor will violently return five years later, and it will be completely immune to the drugs that killed its clones. Breast Cancer Stem Cells & Therapy Resistance is a fiercely advanced, highly specialized molecular biology manual detailing this exact catastrophe. This volume provides the precise genetic blueprints required to hunt and destroy the immortal seeds of relapse.

Mastering the CD44+/CD24- Phenotype

The core philosophy of this text is identifying the apex predator. The authors aggressively detail the mechanics of cellular hierarchy. It dictates exactly how to use flow cytometry to identify the 1% of cells in a tumor that actually possess the power to regenerate the entire mass, proving mathematically that standard chemotherapy actually *enriches* the tumor for these stem cells by killing off only the weak, rapidly dividing daughter cells.

Navigating the Dormancy Switch

The book provides a masterclass in the biology of the ambush. It dictates the exact molecular pathways of metastatic hibernation. It rigorously explores how a breast cancer stem cell can travel to the bone marrow, turn off its division cycle, and sleep for a decade—completely invisible to chemotherapy (which only kills dividing cells)—before suddenly waking up to destroy the patient’s skeleton.

Frequently Asked Questions (FAQs)

Does this book provide standard dosing guidelines for Herceptin or Taxol?
No, it is a highly advanced *molecular oncology, stem cell biology, and translational research textbook* focused entirely on the microscopic mechanics of why those drugs eventually fail.

Who is the primary audience?
It is the absolute, mandatory benchtop reference for Cancer Biologists, Stem Cell Researchers, Molecular Oncologists, and Pharmacologists.